These data represent the largest and most comprehensive evaluation of the effects of SGLT2 inhibitors on clinical outcomes with and without GLP-1 receptor agonists, Brendon Neuen , MBBS, MSc, PhD, associate professor, nephrologist and director of kidney trials at Royal North Shore Hospital and senior research fellow at The George Institute for Global Health in Sydney, told Healio
People living with obesity are at increased risk of developing over 230 complications, including cancer, type 2 diabetes, heart disease, liver diseases and kidney diseases
The demand for oral tirzepatide created a market for fraud
It is the appetite-stimulating effect that dominates its perceived clinical profile and makes it a valuable tool for studying the orexigenic regulation of the GH-ghrelin axis
Glutathione for skin whitening is a trending option among individuals looking for effective solutions